drugset / Trial / NCT06544694
A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the effect of AR-15512 ophthalmic solution 0.003% (0.003% AR-15512) on ocular surface characteristics of subjects with dry eye disease (DED).
Timeline
- Start
- 2024-10-08
- Primary completion
- 2025-03-21
- Completion
- 2025-03-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acoltremon | Small molecule | 0.003 % | Topical |